Acadia Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
18.75
+0.61 (3.36%)
At close: Nov 13, 2026, 4:00 PM EST
18.80
+0.05 (0.27%)
Pre-market: Nov 16, 2026, 7:00 AM EST

Acadia Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
322.37177.7319.59188.66114.85147.44
Short-Term Investments
654.08641.99436.4250.21301.98373.27
Cash & Short-Term Investments
976.45819.69755.99438.87416.82520.71
Cash Growth
15.28%8.43%72.26%5.29%-19.95%-17.60%
Accounts Receivable
161.02121.4698.7498.2762.264.37
Other Receivables
17.326.775.964.080.890.98
Receivables
178.32148.23104.7102.3563.0865.34
Inventory
40.3634.6721.9535.826.647.88
Prepaid Expenses
73.3159.5355.6839.0921.423.89
Total Current Assets
1,2681,062938.32616.13507.94617.82
Property, Plant & Equipment
85.8754.8750.7956.4761.5966.32
Long-Term Investments
-----3.6
Other Intangible Assets
135.48108.89119.7865.49--
Long-Term Deferred Tax Assets
226.72249.88----
Other Long-Term Assets
77.6588.4578.8710.8718.2812.38
Total Assets
1,7941,5641,188748.96587.81700.12

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
16.3310.916.1917.5412.756.88
Accrued Expenses
266.36254.27254.44196.16103.5880.89
Current Portion of Leases
14.5311.639.969.419.318.3
Current Income Taxes Payable
-0.312.021.56--
Other Current Liabilities
35-102.2629.58--
Total Current Liabilities
332.22277.11394.87254.25125.6396.07
Long-Term Leases
57.3240.5542.0447.852.756.13
Other Long-Term Liabilities
17.1219.1418.0615.159.077.03
Total Liabilities
406.66336.81454.96317.2187.4159.23

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.020.020.020.020.020.02
Additional Paid-In Capital
3,1153,0392,9372,8632,7712,695
Retained Earnings
-1,725-1,813-2,204-2,431-2,370-2,154
Comprehensive Income & Other
-2.941.450.290.02-0.98-0.19
Shareholders' Equity
1,3871,227732.79431.76400.41540.89
Total Liabilities & Equity
1,7941,5641,188748.96587.81700.12

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
71.8552.195257.216264.43
Net Cash (Debt)
904.59767.5704381.66354.82456.28
Net Cash Growth
14.19%9.02%84.46%7.56%-22.23%-21.66%
Net Cash Per Share
5.224.524.232.332.192.84
Filing Date Shares Outstanding
172.83170.49166.79164.77162.23161.2
Total Common Shares Outstanding
172.79170.31166.71164.65162.06161.01
Working Capital
936.21785543.45361.87382.31521.76
Book Value Per Share
8.037.214.402.622.473.36
Tangible Book Value
1,2521,118613.01366.27400.41540.89
Tangible Book Value Per Share
7.256.573.682.222.473.36
Machinery
-9.0910.1610.4210.4210.54
Construction In Progress
-3.260.52---
Leasehold Improvements
-4.643.753.753.73.7
SEC Filings: 10-K · 10-Q